Statin therapy in people with diabetes and high-risk patients.
Lipid lowering forms part of the treatment of atherosclerosis. Primary prevention is dependent on identification and treatment of patients at high risk of which patients with diabetes are the clearest example. This article reviews the role of lipid lowering in high-risk individuals.
Wierzbicki
Anthony S
AS
St. Thomas' Hospital, London SE1 7EH.
D001161:Arteriosclerosis / Q000517:prevention & control; D008078:Cholesterol, LDL / Q000097:blood; D002986:Clinical Trials as Topic; D003925:Diabetic Angiopathies / Q000517:prevention & control*; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use*; D006949:Hyperlipidemias / Q000517:prevention & control; D008055:Lipids / Q000097:blood*; D012307:Risk Factors
D008078:Cholesterol, LDL; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D008055:Lipids